Citations

Mayo Clinic

Showing 10 of 108523 citations.

Weak peristalsis with large breaks in chronic cough: association with poor esophageal clearance
Smith, John A. , Valdramidou, D., Lee, A. S., DeVault, Kenneth R. , Houghton, Lesley A. , Almansa, Cristina , Morris, Jonathan , Crowell, Michael D. , Houghton, L A

Neurogastroenterology & Motility | January 28, 2015 | Volume: 27 | Issue: 3 | Pages: 431-442

10.1111/nmo.12513 | PMID 25628004 Get It

AbstractBackgroundGastroesophageal reflux plays an important role in chronic cough (CC). Whether disturbed esophageal motility contributes to increased esophageal reflux exposure or interferes with swallowed bolus clearance is unclear. This study used high resolution esophageal manometry and impedance (HRIM) together with Chicago Classification, and 24‐h impedance pH (MII/pH) to address these questions in patients with CC compared with heartburn (HB).MethodsA retrospective review of 32 patients with CC (mean age 57 [95% CI: 52–62] years) and 32 patients with symptoms of HB (55 [52–62] years) referred for HRIM and MII/pH between September 2012 and September 2013 was undertaken.Key ResultsWeak peristalsis with large breaks (WPLBs) was observed in 34% of CC patients compared with only 12% of HB patients (p = 0.027). Pathological acid exposure time (AET) was identified in 81% of CC patients with WPLBs compared with 29% without (p = 0.011). Increased AET was associated with prolonged clearance time of refluxed events (p = 0.006) rather than increased number of events. AET correlated with the percentage of peristaltic events with large breaks in CC (ρ = 0.467, p = 0.007). Similar data were obtained for total bolus (acid and non‐acid) exposure time. Only one of the CC patients with WPLBs exhibited complete bolus transit (CBT) on swallowing compared with 81% without WPLBs (p < 0.001). Moreover, the percentage of peristaltic events associated with CBT negatively correlated with the percentage of peristaltic events with large breaks (r = −0.653, p < 0.001) in CC.Conclusions & InferencesOne‐third of CC patients exhibit WPLBs, which directly impacts on clearance of refluxed events and bolus's swallowed. These observations may have important implications for esophageal‐bronchial interaction in CC.
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
Palumbo, Antonio , Bringhen, Sara , Mateos, María‐Victoria , Larocca, Alessandra , Kumar, Shaji , Offidani, Massimo , Evangelista, Andrea , Zweegman, Sonja , Musto, Pellegrino , Terpos, Evangelos , Belch, Andrew , Hájek, Roman , Stewart, A. Keith, Moreau, Philippe , Durie, Brian G.M. , Dimopoulos, Meletios Α. , Miguel, Jesús F. San , Richardson, Paul G. , Sonneveld, Pieter , Facon, Thierry T.F. , McCarthy, Philip L. , Lonial, Sagar , Zweegman, Sonja , Ludwig, Heinz , Anderson, Kenneth C. , Einsele, Hermann , Landgren, Ola , Richardson, Paul Gerard Guy , Rajkumar, S. Vincent , Hajek, Roman , Dimopoulos, Meletios A , Moreau, Philippe , Terpos, Evangelos , San-Miguel, Jesus

Blood | January 28, 2015 | Volume: 125 | Issue: 13 | Pages: 2068-2074

10.1182/blood-2014-12-615187 | PMID 25628469 Get It

Key Points Elderly patients with myeloma are heterogeneous and assessment strategies are needed to define the frailty profile. The proposed frailty score aims to better assess patients and provide them with more suitable therapies.
Profound Hypoglycemia with Ecstasy Intoxication
Carrera, Perliveh, Iyer, Vivek

Case Reports in Emergency Medicine | January 27, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-2

10.1155/2015/483153 | PMID 25692049 Get It

Background.3,4-Methylenedioxymethamphetamine (MDMA) or ecstasy is a synthetic drug that is commonly abused for its stimulant and euphoric effects. Adverse MDMA effects include hyperthermia, psychomotor agitation, hemodynamic compromise, renal failure, hyponatremia, and coma. However, endogenous hyperinsulinemia with severe persistent hypoglycemia has not been reported with MDMA use.Case Report.We report the case of a 29-year-old woman who remained severely hypoglycemic requiring continuous intravenous infusion of high-dose dextrose solutions for more than 24 hours after MDMA intoxication. Serum insulin and C-peptide levels confirmed marked endogenous hyperinsulinemia as the cause of the severe hypoglycemia.Why Should an Emergency Physician Be Aware of This?Immediate and frequent monitoring of blood glucose should be instituted in patients presenting with MDMA ingestion particularly if found to be initially hypoglycemic. Early recognition can help prevent the deleterious effects of untreated hypoglycemia that can add to the morbidity from MDMA use. Clinicians need to be aware of this side effect of MDMA so they can carefully monitor and treat it, especially in patients presenting with altered mental status.
MEN1 Mutations in Hürthle Cell (Oncocytic) Thyroid Carcinoma
Kasaian, Katayoon, Chindris, Ana-Maria, Wiseman, Sam M. , Mungall, Karen , Zeng, Thomas, Tse, Kane, Schein, Jacqueline E., Rivera, Michael , Necela, Brian M. , Kachergus, Jennifer M., Casler, John D., Mungall, Andrew J. , Moore, Richard A. , Marra, Marco A. , Copland, John A. , Thompson, E. Aubrey , Smallridge, Robert C., Jones, Steven J.M. , Kasaian, Katayoon, Chindris, Ana-Maria , Mungall, Andrew J

The Journal of Clinical Endocrinology & Metabolism | January 27, 2015 | Volume: 100 | Issue: 4 | Pages: E611-E615

10.1210/jc.2014-3622 | PMID 25625803 Get It

Context and Objective:Oncocytic thyroid carcinoma, also known as Hürthle cell thyroid carcinoma, accounts for only a small percentage of all thyroid cancers. However, this malignancy often presents at an advanced stage and poses unique challenges to patients and clinicians. Surgical resection of the tumor accompanied in some cases by radioactive iodine treatment, radiation, and chemotherapy are the established modes of therapy. Knowledge of the perturbed oncogenic pathways can provide better understanding of the mechanism of disease and thus opportunities for more effective clinical management.Design and Patients:Initially, two oncocytic thyroid carcinomas and their matched normal tissues were profiled using whole genome sequencing. Subsequently, 72 oncocytic thyroid carcinomas, one cell line, and five Hürthle cell adenomas were examined by targeted sequencing for the presence of mutations in the multiple endocrine neoplasia I (MEN1) gene.Results:Here we report the identification of MEN1 loss-of-function mutations in 4% of patients diagnosed with oncocytic thyroid carcinoma. Whole genome sequence data also revealed large regions of copy number variation encompassing nearly the entire genomes of these tumors.Conclusion:Menin, a ubiquitously expressed nuclear protein, is a well-characterized tumor suppressor whose loss is the cause of MEN1 syndrome. Menin is involved in several major cellular pathways such as regulation of transcription, control of cell cycle, apoptosis, and DNA damage repair pathways. Mutations of this gene in a subset of Hürthle cell tumors point to a potential role for this protein and its associated pathways in thyroid tumorigenesis.
The thrombin receptor is a critical extracellular switch controlling myelination
Yoon, Hyesook, Drucker, Kristen , Scarisbrick, Isobel A. , Radulovic, Maja , Wu, Jianmin , Drucker, Kristen L

Glia | January 27, 2015 | Volume: 63 | Issue: 5 | Pages: 846-859

10.1002/glia.22788 | PMID 25628003 Get It

Hemorrhagic white matter injuries in the perinatal period are a growing cause of cerebral palsy yet no neuroprotective strategies exist to prevent the devastating motor and cognitive deficits that ensue. We demonstrate that the thrombin receptor (protease‐activated receptor 1, PAR1) exhibits peak expression levels in the spinal cord at term and is a critical regulator of the myelination continuum from initiation to the final levels achieved. Specifically, PAR1 gene deletion resulted in earlier onset of spinal cord myelination, including substantially more Olig2‐positive oligodendrocytes, more myelinated axons, and higher proteolipid protein (PLP) levels at birth. In vitro, the highest levels of PAR1 were observed in oligodendrocyte progenitor cells (OPCs), being reduced with differentiation. In parallel, the expression of PLP and myelin basic protein (MBP), in addition to Olig2, were all significantly higher in cultures of PAR1−/− oligodendroglia. Moreover, application of a small molecule inhibitor of PAR1 (SCH79797) to OPCs in vitro increased PLP and MBP expression. Enhancements in myelination associated with PAR1 genetic deletion were also observed in adulthood as evidenced by higher amounts of MBP and thickened myelin sheaths across large, medium, and small diameter axons. Enriched spinal cord myelination in PAR1−/− mice was coupled to increases in extracellular‐signal‐regulated kinase 1/2 and AKT signaling developmentally. Nocturnal ambulation and rearing activity were also elevated in PAR1−/− mice. These studies identify the thrombin receptor as a powerful extracellular regulatory switch that could be readily targeted to improve myelin production in the face of white matter injury and disease. GLIA 2015;63:846–859
“The Balloon Plug Concept” for Tricuspid Valve Repair Ex Vivo Proof of Concept
Bajona, Pietro, Salizzoni, Stefano , Vandenberghe, Stijn , Speziali, Giovanni, Zehr, Kenton J., Bruce, Charles J.

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery | January 27, 2015 | Volume: 10 | Issue: 1 | Pages: 27-32

10.1097/imi.0000000000000124 | PMID 25628253 Get It

Objective Functional tricuspid regurgitation (TR) is recognized as a significant cause of morbidity and mortality in cardiothoracic surgery. We hypothesized that a variably expandable, transvalvular balloon mounted on a catheter could be percutaneously inserted and fixed to the right ventricle apex. This novel approach could provide a minimally invasive way to eliminate clinically relevant TR caused by annular dilatation. This study was performed to test the ex vivo hemodynamic effects and the feasibility of the “balloon plug concept.” Methods Twenty harvested calf tricuspid valves were placed in a mechanical simulator. Tricuspid regurgitation was created by annular stretching and displacement of the papillary muscles so as to create central TR. A flexible catheter with a 4-cm–long, soft, fusiform balloon was positioned across the valve so that the balloon was suspended centrally across the valve annular plane. After activating the mechanical ventricle, data were collected with balloon inflation volumes of saline from 5 to 20 mL. Transvalvular pressure gradients and leaflet mechanics were evaluated with incremental inflation. Results In all cases, 5-mL inflation did not significantly reduce TR and 20-mL inflation caused obstruction to antegrade flow (mean transvalvular gradient > 4 mm Hg). Inflation between 10 and 15 mL caused significant reduction in TR with acceptable transvalvular gradients (<3 mm Hg). Conclusions The balloon plug concept showed promising ex vivo hemodynamic results. In vivo investigations are warranted to evaluate percutaneous techniques, thrombogenicity, and effects of repeated balloon-leaflet contact on valve integrity.
A systematic review of validity evidence for checklists versus global rating scales in simulation‐based assessment
Ilgen, Jonathan S. , Ma, Irene , Hatala, Rose , Cook, David A.

Medical Education | January 27, 2015 | Volume: 49 | Issue: 2 | Pages: 161-173

10.1111/medu.12621 | PMID 25626747 Get It

Context The relative advantages and disadvantages of checklists and global rating scales ( GRS s) have long been debated. To compare the merits of these scale types, we conducted a systematic review of the validity evidence for checklists and GRS s in the context of simulation‐based assessment of health professionals. Methods We conducted a systematic review of multiple databases including MEDLINE , EMBASE and S copus to F ebruary 2013. We selected studies that used both a GRS and checklist in the simulation‐based assessment of health professionals. Reviewers working in duplicate evaluated five domains of validity evidence, including correlation between scales and reliability. We collected information about raters, instrument characteristics, assessment context, and task. We pooled reliability and correlation coefficients using random‐effects meta‐analysis. Results We found 45 studies that used a checklist and GRS in simulation‐based assessment. All studies included physicians or physicians in training; one study also included nurse anaesthetists. Topics of assessment included open and laparoscopic surgery ( n = 22), endoscopy ( n = 8), resuscitation ( n = 7) and anaesthesiology ( n = 4). The pooled GRS –checklist correlation was 0.76 (95% confidence interval [ CI ] 0.69–0.81, n = 16 studies). Inter‐rater reliability was similar between scales ( GRS 0.78, 95% CI 0.71–0.83, n = 23; checklist 0.81, 95% CI 0.75–0.85, n = 21), whereas GRS inter‐item reliabilities (0.92, 95% CI 0.84–0.95, n = 6) and inter‐station reliabilities (0.80, 95% CI 0.73–0.85, n = 10) were higher than those for checklists (0.66, 95% CI 0–0.84, n = 4 and 0.69, 95% CI 0.56–0.77, n = 10, respectively). Content evidence for GRS s usually referenced previously reported instruments ( n = 33), whereas content evidence for checklists usually described expert consensus ( n = 26). Checklists and GRS s usually had similar evidence for relations to other variables. Conclusions Checklist inter‐rater reliability and trainee discrimination were more favourable than suggested in earlier work, but each task requires a separate checklist. Compared with the checklist, the GRS has higher average inter‐item and inter‐station reliability, can be used across multiple tasks, and may better capture nuanced elements of expertise.
Model for Individualized Prediction of Breast Cancer Risk After a Benign Breast Biopsy
Frank, Ryan D. , Frost, Marlene H., Visscher, Daniel W., Vierkant, Robert A. , Ghosh, Karthik, Tarabishy, Yaman, Vachon, Celine M. , Hartmann, Lynn C. , Radisky, Derek C. , Pankratz, V. Shane , Degnim, Amy C. , Hieken, Tina J. , Vachon, Celine M. , Vierkant, Robert A

Journal of Clinical Oncology | January 26, 2015 | Volume: 33 | Issue: 8 | Pages: 923-929

10.1200/jco.2014.55.4865 | PMID 25624442 Get It

Purpose Optimal early detection and prevention for breast cancer depend on accurate identification of women at increased risk. We present a risk prediction model that incorporates histologic features of biopsy tissues from women with benign breast disease (BBD) and compare its performance to the Breast Cancer Risk Assessment Tool (BCRAT). Methods We estimated the age-specific incidence of breast cancer and death from the Mayo BBD cohort and then combined these estimates with a relative risk model derived from 377 patient cases with breast cancer and 734 matched controls sampled from the Mayo BBD cohort to develop the BBD–to–breast cancer (BBD-BC) risk assessment tool. We validated the model using an independent set of 378 patient cases with breast cancer and 728 matched controls from the Mayo BBD cohort and compared the risk predictions from our model with those from the BCRAT. Results The BBD-BC model predicts the probability of breast cancer in women with BBD using tissue-based and other risk factors. The concordance statistic from the BBD-BC model was 0.665 in the model development series and 0.629 in the validation series; these values were higher than those from the BCRAT (0.567 and 0.472, respectively). The BCRAT significantly underpredicted breast cancer risk after benign biopsy (P = .004), whereas the BBD-BC predictions were appropriately calibrated to observed cancers (P = .247). Conclusion We developed a model using both demographic and histologic features to predict breast cancer risk in women with BBD. Our model more accurately classifies a woman's breast cancer risk after a benign biopsy than the BCRAT.
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
Savona, Michael R. , Malcovati, Luca , Komrokji, Rami S. , Tiu, Ramón V., Mughal, Tariq I. , Orazi, Attilio , Kiladjian, Jean‐Jacques , Padron, Eric , Solary, Éric , Tibes, Raoul , Itzykson, Raphaël , Cazzola, Mario , Maciejewski, Jaroslaw P. , Fenaux, Pierre , Garcia‐Manero, Guillermo , Gerds, Aaron T. , Sanz, Guillermo , Cervantes, Francisco , Germing, Ulrich, Cross, Nicholas C.P. , List, Alan F. , Mesa, Ruben, Mesa, Ruben A. , Niemeyer, Charlotte Marie , Germing, Ulrich , Gerds, Aaron T , Savona, Michael R , Komrokji, Rami S , Solary, Eric , Kiladjian, Jean-Jacques , Itzykson, Raphael , Malcovati, Luca , Cazzola, Mario , Sanz, Guillermo F , Orazi, Attilio , Cross, Nicholas C P

Blood | January 26, 2015 | Volume: 125 | Issue: 12 | Pages: 1857-1865

10.1182/blood-2014-10-607341 | PMID 25624319 Get It

Abstract Myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN) are hematologically diverse stem cell malignancies sharing phenotypic features of both myelodysplastic syndromes and myeloproliferative neoplasms. There are currently no standard treatment recommendations for most adult patients with MDS/MPN. To optimize efforts to improve the management and disease outcomes, it is essential to identify meaningful clinical and biologic end points and standardized response criteria for clinical trials. The dual dysplastic and proliferative features in these stem cell malignancies define their uniqueness and challenges. We propose response assessment guidelines to harmonize future clinical trials with the principal objective of establishing suitable treatment algorithms. An international panel comprising laboratory and clinical experts in MDS/MPN was established involving 3 independent academic MDS/MPN workshops (March 2013, December 2013, and June 2014). These recommendations are the result of this collaborative project sponsored by the MDS Foundation.